Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.


Delayed Data
As of Feb 24
 -0.17 / -0.40%
Today’s Change
Today|||52-Week Range
Mylan (MYL) to Post Q4 Earnings: Will the Stock Disappoint?
Feb 24 / Zacks.com - Paid Partner Content
Where Are the Best Buying Opportunities in Stocks Right Now?
Feb 21 / Zacks.com - Paid Partner Content
Fore Research & Management, LP Buys CA, Vodafone Group PLC, LiLAC Group, Sells Centra...
Feb 23 / GuruFocus News - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
Feb 22 / GuruFocus News - Paid Partner Content
Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
Feb 16 / MotleyFool.com - Paid Partner Content
Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat
Feb 22 / MotleyFool.com - Paid Partner Content
Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance
Feb 14 / Zacks.com - Paid Partner Content
Drug Addiction Treatment Stocks to Watch
Feb 22 / GuruFocus News - Paid Partner Content